Ticker
ENTXCompany Name
ENTERA BIO LTDSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Debt | Shareholders Equity | Invested Capital |
---|---|---|---|
6/30/2025 | $ 203K | $ 17.26M | $ 17.46M |
3/31/2025 | $ 220K | $ 19.38M | $ 19.6M |
12/31/2024 | $ 272K | $ 8.08M | $ 8.35M |
9/30/2024 | $ 309K | $ 6.45M | $ 6.76M |
6/30/2024 | $ 334K | $ 8.53M | $ 8.87M |
3/31/2024 | $ 377K | $ 8.86M | $ 9.24M |
12/31/2023 | $ 390K | $ 10.39M | $ 10.78M |
9/30/2023 | $ 402K | $ 6.24M | $ 6.64M |
6/30/2023 | $ 456K | $ 8.23M | $ 8.69M |
3/31/2023 | $ 48K | $ 10.08M | $ 10.13M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Debt + Equity
(=) Inv. Capital
Inv. Capital for ENTERA BIO LTD is calculated as follows: Debt [ $ 216K ] + Equity [ $ 5.74M ]
(=) Inv. Capital [ $ 5.96M ]
Minimum
Sep 30, 2020
Maximum
Sep 30, 2021
Average
Median
filtered constituents | 3.44K |
---|---|
min | $ -1.51B |
max | $ 4.14B |
average | $ 762.5M |
median | $ 304.41M |
std | $ 1B |